[P-6] Poster Talk6

[P6-26] Development of Pf-Pv malaria bivalent vaccine based on a next-generation viral vector platform (LC16m8Δ/AAV)

*Takuto Katayama¹, Yutaro Yamamoto¹, Daiki Okuhara¹, Mitsuhiro Iyori^2,1, Hiroaki Mizukami³, Hisatoshi Sida⁴, Shigeto Yoshida¹ (1. Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, 2. Musashino University School of Pharmacy, Musashino University, 3. Division of Gene Therapy, Jichi Medical University, 4. Institute for Genetic Medicine, Hokkaido University)